Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

High-resolution heart ultrasound a must in draft NHS (National Health Service) policy:

This article was originally published in Clinica

Executive Summary

Doppler 2D echocardiographic assessments of potential valve disease will be performed by the NHS only on high-resolution equipment, if new guidelines on the management of chronic heart failure are adopted. The final draft document published today (April 8 2003) by the National Institute for Clinical Excellence (NICE) for consultation, sets out the diagnostics technology to be used by such services, including 12-lead ECG and/or natriuretic peptides tests to exclude diagnosis, transthoracic echocardiography to provide further confirmation where appropriate, and a range of other tests, including X-rays, blood tests and urinanalysis. The consultation ends May 2; the guidelines are due to be published in July.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061778

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel